In 2021, Van Poppel et al. [28] published another algorithm for early diagnosis of PCa in a population-based setting that emerged from expert consensus, starting in well-informed men with PSA interval tests, followed by the selection of patients for imaging studies and biopsy based on calculators of PCa risk. The gene discussed is KLK3; the disease is posterior cortical atrophy.